Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Novo Nordisk A/S

Market Cap 1,241B 193B 166B 153B 144B 270B 18,219B 272B 1,807B 704B 8,922B 723B 708B 30,918B P/E Ratio 2026 *
12.4x
P/E Ratio 2027 * 13.3x
Enterprise Value 1,359B 211B 182B 167B 157B 295B 19,945B 298B 1,978B 771B 9,767B 792B 775B 33,848B EV / Sales 2026 *
4.65x
EV / Sales 2027 * 4.54x
Free-Float
71.32%
Yield 2026 *
4.05%
Yield 2027 * 3.88%

Last Transcript: Novo Nordisk A/S

1 day+0.14%
1 week+3.22%
Current month-4.45%
1 month-2.66%
3 months+12.88%
6 months-11.05%
Current year-14.41%
1 week 42.94
Extreme 42.94
44.79
1 month 41
Extreme 41
46.05
Current year 35.12
Extreme 35.12
64.16
1 year 35.12
Extreme 35.12
74.82
3 years 35.12
Extreme 35.12
148.15
5 years 35.12
Extreme 35.12
148.15
10 years 15.44
Extreme 15.445
148.15
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-06
Director of Finance/CFO 55 2018-02-14
Chief Tech/Sci/R&D Officer - 2025-11-04
Director TitleAgeSince
Chairman 71 2025-11-13
Director/Board Member 65 2026-03-25
Director/Board Member 64 2025-11-13
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%+3.22% - - 196B
-0.61%-1.94%+39.00%+150.72% 1,007B
-0.20%-0.77%+51.51%+43.20% 567B
+0.40%-1.31%+16.56%+60.47% 392B
-1.18%+2.29%+24.04%+16.53% 328B
-0.43%+1.12%+24.21%+31.89% 277B
+0.64%-2.55%+22.80%+12.69% 275B
-0.77%+0.95%+17.69%+51.46% 189B
+2.36%+1.38%+14.80%+61.34% 154B
+0.15%+1.32%+6.72%-35.00% 148B
Average +0.04%+0.20%+24.15%+43.70% 370.87B
Weighted average by Cap. -0.18%-0.48%+30.70%+69.43%

Financials

2026 *2027 *
Net sales 292B 45.38B 39.11B 36.02B 33.82B 63.49B 4,291B 64.16B 426B 166B 2,101B 170B 167B 7,282B 298B 46.31B 39.91B 36.75B 34.51B 64.79B 4,379B 65.47B 434B 169B 2,144B 174B 170B 7,431B
Net income 98.69B 15.32B 13.2B 12.16B 11.41B 21.43B 1,448B 21.66B 144B 55.96B 709B 57.49B 56.27B 2,458B 93.73B 14.55B 12.54B 11.55B 10.84B 20.35B 1,376B 20.57B 136B 53.15B 674B 54.6B 53.44B 2,334B
Net Debt 118B 18.26B 15.74B 14.49B 13.6B 25.54B 1,726B 25.81B 171B 66.7B 845B 68.52B 67.07B 2,930B 114B 17.75B 15.3B 14.09B 13.23B 24.83B 1,678B 25.1B 166B 64.85B 822B 66.62B 65.21B 2,848B
Logo Novo Nordisk A/S
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.7%); - rare disease treatment products (6.3%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe and Canada (21.4%), the United States (56%), Latin America/Middle East/Africa (9.9%), China/Hong Kong/Taiwan (6%), Asia/Pacific (6.7%).
Employees
67,900
Date Price Change Volume
26-06-16 43.55 $ -0.84% 7,138,204
26-06-15 43.92 $ +0.09% 10,223,347
26-06-12 43.88 $ -0.18% 14,799,174
26-06-11 43.96 $ +2.69% 12,719,843
26-06-10 42.81 $ +1.47% 16,563,859
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
280.30DKK
Average target price
311.78DKK
Spread / Average Target
+11.23%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!